Karen Luyt holds a tenured clinical-academic position in Neonatal Medicine at the University of Bristol. She works as a clinical neonatologist in the Regional Neonatal Intensive Care unit at St Michael’s Hospital, Bristol, with special interests in brain injury, neuro-intensive care and improving health outcomes in high risk infants. 

Neonatal Neurology and Health Outcomes in high risk infants

Professor Luyt’s laboratory-based research has focused on mechanisms of brain injury and regeneration in the newborn central nervous system. Her translational clinical research concerns evaluation and implementation of evidence-based interventions to reduce neurodisability and mortality in newborns.

 Chief Investigator for:

• School age outcomes of the DRIFT (Drainage, Irrigation, and Fibrinolyitic Therapy) Trial (NIHR funded). Functional outcome and brain imaging in children who received DRIFT for posthaemorrhagic ventricular dilatation.
• PReCePT (Prevention of Cerebral Palsy in Preterm Labour) Study – National cluster randomised controlled trial (Health Foundation funded)

Diseases related to this field of research

• Neurodevelopment
• Neonatal Brain Injury
• Cerebral Palsy
• Health Outcomes
• Neonatal Mortality

Twitter: @Karen.Luyt

Biography

Karen Luyt read medicine in South Africa and received a CCST in Paediatrics (Neonatal Medicine) in the UK in 2004. She was awarded a Walport Senior Lectureship in 2009 and holds a tenured clinical-academic position in Neonatal Medicine at the University of Bristol. She works as a clinical neonatologist in the Regional Neonatal Intensive Care unit at St Michael’s Hospital, Bristol, with special interests in brain injury, neuro-intensive care and improving health outcomes in high risk infants. 

Leadership Roles:

• Programme lead for the National Child Mortality Database (NCMD)
• National clinical lead for the PReCePT (Prevention of Cerebral Palsy in Preterm Labour) Programme
• Strategic clinical lead for the PERIPrem project
• Academic Lead for the Child Death Overview Group